Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global non-surgical aesthetic device company, today announced the successful completion of its...
Syneron Medical Ltd. (NASDAQ: ELOS) today announced that its shareholders have approved the previously announced definitive agreement under which an...
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period ended...
Syneron Medical Ltd. (NASDAQ: ELOS) today announced the expiration of the 37-day "go-shop" period under the terms of the previously announced merger...
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that its Annual Report on Form 20-F, containing...
Total Revenue Grows 5.1% in 4Q16 and 7.3% for Full Year Emerging Products¹ Revenue Grows 25.0% in 4Q16 and 42.1% for Full Year, Reaching $82.7...
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that Hugo Goldman, Chief Financial Officer, and...
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today the strengthening of its executive management team...
Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, today announced that it will release fourth quarter and full year 2016 ...
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that Hugo Goldman, Chief Financial Officer, is...
Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, today announced financial results for the three month period ended...
Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, today announced that it is strengthening its management team with the...
Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today that the PicoWay® picosecond laser received U.S. Food...
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announces the U.S. Food and Drug Administration (FDA) clearance of...
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release second quarter 2016 financial...
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release first quarter 2016 financial...
Syneron Medical Ltd. (NASDAQ: ELOS) a global leader in aesthetic medical devices, today announced the presentation of 11 scientific abstracts at the...
Syneron Medical Ltd. (NASDAQ: ELOS) a leading global aesthetic device company, and Allergan plc, (NYSE: AGN) a leading global pharmaceutical company, ...
Syneron Medical Ltd. (NASDAQ: ELOS) a global market leader in the aesthetic medical device marketplace, this week will announce three new product...
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three and twelve month...
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that William Griffing, Chief Executive Officer of...
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that it will release fourth quarter 2015 and full...
Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today provided preliminary unaudited fourth quarter 2015 revenue...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.